Screening for Viral Hepatitis and Hepatocellular Cancer

Area of Science:

• Hepatology
• Viral Hepatitis
• Oncology

Background:

• Hepatitis B virus (HBV), hepatitis C virus (HCV), and hepatocellular carcinoma (HCC) pose significant health risks.
• Early detection and treatment are critical for managing these liver diseases.
• Effective screening, diagnostic tests, and therapeutic options are essential for at-risk populations.

Purpose of the Study:

• To highlight the availability of accurate diagnostic tests for HBV, HCV, and HCC.
• To emphasize the importance of early diagnosis and effective treatments for these conditions.
• To underscore the rationale for screening and surveillance programs.

Main Methods:

• Review of current diagnostic and therapeutic strategies for HBV, HCV, and HCC.
• Analysis of the criteria for implementing effective screening and surveillance programs.
• Assessment of the impact of new treatments on HCV management.

Main Results:

• Accurate and accessible tests for HBV, HCV, and HCC are available for targeted populations.
• Effective treatments exist for all three conditions, particularly when diagnosed early.
• New antiviral therapies are significantly improving outcomes for HCV patients.
• Liver transplantation offers a curative option for early-stage HCC.

Conclusions:

• Screening and surveillance for HBV, HCV, and HCC are highly effective when targeted at identified at-risk groups.
• The availability of sensitive, specific, low-cost tests and effective treatments justifies these public health initiatives.
• Timely diagnosis and intervention are key to improving patient survival and quality of life for liver diseases.